UFP Technologies, Inc. logo

UFP Technologies, Inc.

UFPT

NASDAQHealthcareMedical - Devices

Previous close

$309.13

+$4.88 · +1.60%

Aug 21, 4:00 PM ET

Pre-market

$310.61

+$1.48 · +0.48%

Aug 24, 4:01 AM ET

UFPT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

84

Deep Value

Momentum

52

Neutral

Sentiment

60

Mixed

Risk resilience

64

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US
CEO
Mitchell C. Rock
Listed since
Dec 17, 1993
Employees
4,846

Market position

Day range

Current $309.13

52-week range

Current $309.13

Open
$306.04
Previous close
$304.25
Volume
142.83K
0.68× average
Average volume
210.21K
Average daily volume
Market cap
2.39B USD
Beta
1.06
Market reference 1
50-day average
$267.62
+15.51% above average
200-day average
$234.04
+32.08% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.84B USD
EV / EBITDA
15.94×
Earnings yield
3.99%
Free cash flow yield
4.62%

Profitability & efficiency

Return on equity
16.12%
Return on assets
10.26%
Return on invested capital
12.57%

Financial health

Current ratio
2.68×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends31%23%14%6%Gross margin, FY2021: 24.77%Gross margin, FY2022: 25.51%Gross margin, FY2023: 28.05%Gross margin, FY2024: 29.08%Gross margin, FY2025: 28.27%Operating margin, FY2021: 10.28%Operating margin, FY2022: 15.66%Operating margin, FY2023: 14.41%Operating margin, FY2024: 16.04%Operating margin, FY2025: 15.32%Net margin, FY2021: 7.70%Net margin, FY2022: 11.81%Net margin, FY2023: 11.23%Net margin, FY2024: 11.69%Net margin, FY2025: 11.33%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 24.77%. Gross margin FY2022 25.51%. Gross margin FY2023 28.05%. Gross margin FY2024 29.08%. Gross margin FY2025 28.27%. Operating margin FY2021 10.28%. Operating margin FY2022 15.66%. Operating margin FY2023 14.41%. Operating margin FY2024 16.04%. Operating margin FY2025 15.32%. Net margin FY2021 7.70%. Net margin FY2022 11.81%. Net margin FY2023 11.23%. Net margin FY2024 11.69%. Net margin FY2025 11.33%.

Income trends

Revenue

602.8M USD+19.50%

Operating income

92.34M USD+14.14%

Net income

68.31M USD+15.82%
Income trends across reported periods661.49M USD426.72M USD191.96M USD−42.81M USDRevenue, FY2021: 206.32M USDRevenue, FY2022: 353.79M USDRevenue, FY2023: 400.07M USDRevenue, FY2024: 504.42M USDRevenue, FY2025: 602.8M USDOperating income, FY2021: 21.22M USDOperating income, FY2022: 55.4M USDOperating income, FY2023: 57.66M USDOperating income, FY2024: 80.9M USDOperating income, FY2025: 92.34M USDNet income, FY2021: 15.89M USDNet income, FY2022: 41.79M USDNet income, FY2023: 44.92M USDNet income, FY2024: 58.98M USDNet income, FY2025: 68.31M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 206.32M USD. Revenue FY2022 353.79M USD. Revenue FY2023 400.07M USD. Revenue FY2024 504.42M USD. Revenue FY2025 602.8M USD. Operating income FY2021 21.22M USD. Operating income FY2022 55.4M USD. Operating income FY2023 57.66M USD. Operating income FY2024 80.9M USD. Operating income FY2025 92.34M USD. Net income FY2021 15.89M USD. Net income FY2022 41.79M USD. Net income FY2023 44.92M USD. Net income FY2024 58.98M USD. Net income FY2025 68.31M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue602.8M USD504.42M USD400.07M USD353.79M USD206.32M USD
Cost of goods sold432.39M USD357.73M USD287.85M USD263.53M USD155.21M USD
Gross profit170.41M USD146.69M USD112.23M USD90.26M USD51.11M USD
Selling, general, and administrative77.44M USD62.22M USD50.89M USD45.8M USD29.48M USD
Operating expenses78.07M USD65.8M USD54.56M USD34.86M USD29.9M USD
Interest income49K USD
Interest expense9.8M USD8.06M USD3.65M USD2.76M USD39K USD
Depreciation and amortization23.43M USD14.72M USD11.41M USD11.89M USD8.41M USD
Operating income92.34M USD80.9M USD57.66M USD55.4M USD21.22M USD
Net income68.31M USD58.98M USD44.92M USD41.79M USD15.89M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+18.42%
11 comparable reports
Latest EPS result
2.69
Estimate 2.31 · Beat by 16.45%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.82.492.181.87Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 2.46, estimate 1.98, surprise +24.24%, Beat. Q2 2025, reported May 6, 2025: actual 2.47, estimate 2.05, surprise +20.49%, Beat. Q3 2025, reported Aug 4, 2025: actual 2.5, estimate 2.29, surprise +9.17%, Beat. Q4 2025, reported Nov 3, 2025: actual 2.39, estimate 2.22, surprise +7.66%, Beat. Q1 2026, reported Feb 24, 2026: actual 2.44, estimate 2.26, surprise +7.96%, Beat. Q2 2026, reported May 4, 2026: actual 2.27, estimate 2.18, surprise +4.13%, Beat. Q3 2026, reported Aug 3, 2026: actual 2.69, estimate 2.31, surprise +16.45%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 2.63, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates180.92M165.52M150.11M134.71MQ1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 144.07M USD, estimate 141.67M USD, surprise +1.70%, Beat. Q2 2025, reported May 6, 2025: actual 148.15M USD, estimate 145.09M USD, surprise +2.11%, Beat. Q3 2025, reported Aug 4, 2025: actual 151.18M USD, estimate 152.44M USD, surprise -0.83%, Miss. Q4 2025, reported Nov 3, 2025: actual 154.56M USD, estimate 149.07M USD, surprise +3.68%, Beat. Q1 2026, reported Feb 24, 2026: actual 148.92M USD, estimate 149.07M USD, surprise -0.11%, Miss. Q2 2026, reported May 4, 2026: actual 154.2M USD, estimate 154.78M USD, surprise -0.37%, Miss. Q3 2026, reported Aug 3, 2026: actual 173.96M USD, estimate 159.38M USD, surprise +9.15%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 166.89M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$298

3.60% downside
Past 12 months12-month forecastHigh $344Average $298Low $252

UFPT peers

ETFs holding UFPT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research UFPT

research.disclaimer